TEIPP Immunotherapy in Patients With NSCLC

Clinical trial NCT05898763 · COMPLETED

Trial details

NCT number: NCT05898763
Sponsor: Erasmus Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2021-09-29
Primary completion: 2024-04-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.